Risk factors in carcinoma in situ of the urinary bladder
Authors:
- Frans M.J. DebruyneFDFrans M.J. Debruyne
- Wim P.J. WitjesWWWim P.J. Witjes
- J. Alfred WitjesJWJ. Alfred Witjes
- Christine T.M. CarisCCChristine T.M. Caris
- Gosse O.N. OosterhofGOGosse O.N. Oosterhof
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice, and BCG-RIVM in pTa-pT1 tumours and primary carcinoma in situ of the urinary bladderEuropean Journal of Cancer, 1993
- Karyometry in recurrent superficial transitional cell tumors of the bladderUrological Research, 1992
- Long-term complete remission inbladder carcinoma in situ with intravesical tice bacillus Calmette guerinUrology, 1991
- The Fate of G3pT1 Bladder CancerBritish Journal of Urology, 1989
- Long-Term Results of Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder CancerJournal of Urology, 1989
- Summary of Workshop on Carcinoma in Situ of the BladderJournal of Urology, 1986
- Long-Term Effect of Intravesical Bacillus Calmette-Guerin on Flat Carcinoma in Situ of the BladderJournal of Urology, 1986
- Topical Doxorubicin Hydrochloride Therapy for Carcinoma in Situ of the Bladder: A FollowupJournal of Urology, 1984
- Prognostic Factors Influencing Survival of Patients Receiving Intravesical EpodylJournal of Urology, 1982
- Histological Study of Vesical Urothelium Intervening Between Gross Neoplasms in Total CystectomyJournal of Urology, 1952